Trinity Capital (TRIN) announced the commitment of $30M in growth capital to Elucent Medical, a medical technology company in the field of guided surgical technologies. Based in Eden Prairie, Minnesota, Elucent developed the EnVisio System, which uses a spatial field generator measuring continuous data points across multiple planes, to display exact 3D positioning of the SmartClip marker and SmartSensor used to guide soft-tissue surgical excision. EnVisio’s adaptive design and seamless integration redefine surgical precision. Earlier in 2024, Elucent raised $44.0M in its Series C funding round. This additional growth capital will be used to scale operations.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TRIN:
- Trinity Capital provides $30M in growth capital to Silk Technologies
- Trinity Capital provides $12.5M in growth capital to Upward Health
- Trinity Capital Achieves Record $1.2 Billion Fundings
- Trinity Capital provides $20M in capital to Steno
- Trinity Capital downgraded to Underweight from Equal Weight at Wells Fargo